|
|
|
Insider
Information: |
Yachmetz Philip K |
Relationship: |
Co-President and CBO |
City: |
Wyckoff |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
98,241 |
|
Indirect Shares
|
200 |
|
|
Direct
Value |
$31,554 |
|
|
Indirect Value
|
$820 |
|
|
Total
Shares |
98,441 |
|
|
Total
Value |
$32,374 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Progenics Pharmaceuticals Inc |
PGNX |
VP, General Counsel |
2004-05-03 |
7,696 |
2004-05-03 |
200 |
Premium* |
|
Savient Pharmaceuticals Inc |
SVNTQ |
Co-President and CBO |
2013-10-15 |
90,545 |
2004-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SVNTQ |
Savient Pharmaceuticals I... |
Co-President and CBO |
|
2013-10-15 |
4 |
S |
$0.09 |
$20,835 |
D/D |
(213,156) |
90,545 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2012-02-01 |
4 |
A |
$2.26 |
$113,000 |
D/D |
50,000 |
239,024 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2007-03-05 |
4 |
A |
$12.51 |
$572,333 |
D/D |
45,750 |
175,547 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2006-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
112,058 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2005-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
32,050 |
42,050 |
|
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2013-02-04 |
4 |
AS |
$1.01 |
$30,837 |
D/D |
(30,500) |
303,701 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP - General Counsel |
|
2009-02-13 |
4 |
A |
$5.94 |
$148,500 |
D/D |
25,000 |
191,691 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP - General Counsel |
|
2009-02-13 |
4/A |
A |
$5.94 |
$148,500 |
D/D |
25,000 |
191,691 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2010-09-16 |
4 |
A |
$20.27 |
$464,548 |
D/D |
22,918 |
193,352 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP - Chief Business Officer |
|
2008-11-04 |
4 |
A |
$5.17 |
$116,325 |
D/D |
22,500 |
168,311 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2007-03-05 |
4 |
AS |
$12.53 |
$261,639 |
D/D |
(20,881) |
154,666 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2007-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,790 |
129,797 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2008-03-05 |
4 |
A |
$23.01 |
$477,458 |
D/D |
20,750 |
159,021 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2006-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
72,050 |
|
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP - General Counsel |
|
2008-12-08 |
4 |
A |
$4.53 |
$67,950 |
D/D |
15,000 |
173,091 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP - Chief Business Officer |
|
2008-11-04 |
4 |
D |
$5.17 |
$52,837 |
D/D |
(10,220) |
158,091 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2004-06-04 |
4 |
A |
$2.89 |
$29,525 |
D/D |
10,000 |
10,000 |
|
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2005-05-18 |
4 |
B |
$3.08 |
$31,840 |
D/D |
10,000 |
52,050 |
2.74 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2008-03-05 |
4 |
D |
$23.49 |
$221,406 |
D/D |
(9,425) |
149,596 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2010-09-16 |
4 |
D |
$20.27 |
$164,552 |
D/D |
(8,118) |
185,234 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
|
2007-12-10 |
4 |
AS |
$15.22 |
$118,344 |
D/D |
(7,774) |
143,087 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2011-09-16 |
4 |
B |
$4.13 |
$28,910 |
D/D |
7,000 |
189,024 |
2.74 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP - General Counsel |
|
2008-12-09 |
4 |
AS |
$4.86 |
$31,104 |
D/D |
(6,400) |
166,691 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP - General Counsel |
|
2009-02-17 |
4 |
AS |
$5.73 |
$33,635 |
D/D |
(5,868) |
185,823 |
0 |
- |
|
SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
|
2010-02-16 |
4 |
AS |
$13.79 |
$79,706 |
D/D |
(5,778) |
167,127 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|